-- Health care stocks were falling premarket Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.2% and the iShares Biotechnology ETF (IBB) 0.7% lower.
Neogen (NEOG) shares were down more than 5% after the company reported lower fiscal Q3 adjusted earnings and revenue.
Novartis (NVS) said it will expand its programs to find and treat patients with heart disease and cancer in "hard-to-reach" communities worldwide. Novartis stock was down more than 1% pre-bell.
GoodRx (GDRX) shares were up more than 2% after the company said it partnered with Eli Lilly (LLY) to expand self-pay purchasing options for two weight management medications, Foundayo and Zepbound KwikPen.